转移后瘤微环境的多组分析:朝着个性化免疫疗法和分子向策略的进步
Qing Gao1, Huqiang Wu2, Li Duan3
1School of Life Sciences, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, China.
Frontiers in immunology
|October 9, 2025
概括
多omics研究揭示了转移性瘤微环境 (TME) 的复杂性. 了解TME分子重编程有助于开发针对晚期癌症的向疗法.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 系统生物学 系统生物学
背景情况:
- 转移性瘤微环境 (TME) 对癌症进展,免疫逃避和治疗耐药性至关重要.
- 了解TME的动态和异质性质是克服转移性疾病的关键.
研究的目的:
- 系统地审查最近关于转移性TME的多学科发现.
- 突出转移和治疗耐药性的分子驱动因素.
- 讨论针对晚期癌症的TME向策略.
主要方法:
- 基因组学就是基因组学.
- 文字转录学 (Transcriptomics) 是一个学科.
- 表观基因组学是指表观基因组学.
- 蛋白质组学是指蛋白质组学.
- 代谢学 代谢学 代谢学
- 综合性的多主题数据分析.
主要成果:
- 多omics研究提供了TME分子重编程的系统层面的观点.
- 确定了驱动转移和抗性的关键分子特征和细胞间相互作用.
- 在转移性TME中阐明了代谢重新连接和免疫景观的改变.
结论:
- 综合的多主题数据有助于确定可操作的目标.
- 新型免疫治疗和精准医学策略可以为转移性利基设计.
- 这些发现支持开发针对高级癌症的TME向疗法.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


